Healthcare News Archivi - Business NewsWire

Safely Testing the Future of Transportation: The Growth of the Driving Simulator Market

The World Health Organization (WHO) estimates that nearly 1.3 million deaths occur due to road traffic crashes each year. The organization also states that road accidents cause non-fatal injuries among 20–50 million people across the globe every year. As per the WHO, road traffic injuries are the major cause of death among young adults and children aged 5–29 years. Most of these accidents are caused due to human mistakes, owing to which driving simulators are being adopted by the transportation and automotive industry.

Additionally, the booming demand for skilled drivers, on account of the increasing penetration of shared mobility fleet and burgeoning need for logistics services from the e-commerce industry, is expected to steer the driving simulator market growth during the forecast years (2020–2030). Besides, the ongoing research and development (R&D) in advanced driving assistance systems (ADAS) will also augment the global demand for driving simulators. According to P&S Intelligence, the market generated $2 billion revenue in 2020.

Driving simulators, such as advanced simulators, compact simulators, and full-scale simulators, are installed in passenger vehicles as well as commercial vehicles. Presently, automobile manufacturers are preferring compact simulators over other variants due to the increasing number of people undergoing driving training on buses, cars, off-highway vehicles, and vans. In comparison to advanced and full-scale simulators, compact simulators are available at a lower cost. In the coming years, the highest quantity of driving simulators will be deployed in passenger vehicles due to the surging focus of manufacturers and drivers of such vehicles on road safety.

Currently, the driving simulator market is consolidated in nature, with the presence of a few players, such as Tecknotrove Simulator System Pvt. Ltd., Corys TESS, Anthony Best Dynamics Limited, Dallara Group Srl, Cassidian, Transurb, Cruden B.V., OKTAL SYDAC, and SHRail. In recent years, these players have launched new products to gain a competitive edge. For example, Anthony Best Dynamics Limited unveiled a static driving simulator in July 2020. This simulator delivers high levels of driver immersion in an era where driver-in-the-loop (DIL) simulation has become extremely important for the delivery of new automobile models in ever-tighter timescales.

Globally, the North American region was the dominant user of driving simulators in the preceding years, owing to the implementation of stringent road safety and traffic control laws and a large number of automobiles running on the roads of the regional countries. Moreover, the rapid advancements in driving simulator technology, to avoid potential failures in vehicles that might result in driver injury, will also facilitate the adoption of driving simulators in the region. For instance, the Bureau of Transportation Statistics states that the number of registered vehicles in the U.S. increased from 273,602,100 in 2018 to 276,491,174 in 2019.

Improving Quality of Life: The Rising Demand for Pressure Relief Devices in the Global Market

The growth of the pressure relief devices market from $3,361.1 million in 2021 to $5,923.9 million by 2030 will be at a 6.5% CAGR during 2021–2030. Currently, low-tech devices are the most popular and account for almost 65% of the sales revenue. They are easy to use, economical, and highly effective in preventing ulcers. There are various low-tech pressure relief devices, among which mattresses that contain foam witness the highest demand. Till 2030, the fastest growth will be in the adoption of gel-based mattresses, as they outperform other types of low-tech devices.

Sales of High-Tech Devices To Grow Swiftly

In the coming years, the demand for high-tech devices is expected to increase at a high pace, as several technological advancements are being brought about in this domain to prevent pressure ulcers.

The faster pressure relief devices market growth would be in the kinetic beds bifurcation. These devices save people on prolonged bedrest from breathing complications. Already popular in Europe and North America, these beds are now also growing in usage in the healthcare settings in developing regions.

Geographical Insights of Pressure Relief Devices Market

The U.S. dominates North America, the largest market around the world, with an around 37% share. The country has a high incidence of pressure ulcers, favorable medical reimbursement scenario, and several government funding schemes.
The second-highest revenue is contributed by Europe, due to the large population with pressure ulcers in Western Europe. Additionally, numerous government and non-government organizations host campaigns to raise awareness on this condition.
Germany is the largest pressure relief devices market in Europe, ascribed to being home to the highest number of people in the elderly demographic.
The third-largest shareholder, APAC will witness a CAGR of 7.2%, the highest in the world. Market players are allying with local vendors in India, South Korea, and China to target the vast customer base here and increase their sales.
China, which is rapidly gaining prominence in the worldwide healthcare ecosystem, is the largest buyer of pressure relief devices in the APAC region. Moreover, apart from local companies, international medical device firms are strengthening their presence in the country.

Growing Urbanization Increasing Need for Last-Mile Delivery

The shifting consumer requirements are responsible for businesses to offer last-mile delivery of products. Be it the residence or retail store, the endpoint should be reached quickly, with the aim of having happy customers. It is also the most expensive phase of the entire journey of a product from the passage hub to its final destination; thus, the requirement for the optimization of resources is being focused upon by shippers as well as retailers and manufacturers.

When an order is placed by a customer on a web browser or mobile application, it connects with the server of the retailer or e-commerce company. The order is then processed by a centralized management system, which confirms if the stock of a certain product is available and offers the customer the option to make an online payment for the shipment asked for. It then directs the concerned warehouse to dispatch the shipment to the consumer. At this point, the role of the last-mile delivery begins. The transporter directs an agent for the collection of the purchased product from the company’s warehouse and delivers it to the customer’s doorstep.

Role of Last-Mile Delivery in Easing Lives during Pandemic

With the outbreak of the pandemic, when people were confined to the four walls of the house and not able to take a foot out, they had little choice but to order food and other stuff online. Businesses with delivery systems saw the opening and added capacity, extended the timings of delivery, and even branched out into more products. Businesses that did not possess their own delivery system banked on third-party delivery services as the main channel to reach the doorstep of customers.
Food delivery platforms Zomato and Swiggy are making significant investments to transform grocery delivery. While Swiggy has invested $700 million to grow its express delivery Instmart, Zomato focusing on acquiring a 10-minute grocery delivery start-up Blinkit.

The focus that shifted toward safety during the pandemic will not suddenly disappear in thin air. Some facets of the alteration in priorities of the consumers from ease to safety and from desires to basic needs may persist.

Use of Autonomous Vehicles Is Rising

To gratify clients who want to buy products online, without any intrusion, the number of delivery vehicles in the leading 100 cities around the globe will rise by 36% by 2030. The adoption of self-driving vehicles is likely to drive a major alteration in the last-mile delivery model. Artificial intelligence is important for autonomous driving systems as it allows consistent and instantaneous recognition of things that are present in their vicinity. The autonomous driving expertise will let to a radical drop in the delivery cost, thus prompting added growth in the volume of e-commerce orders. Novel vehicles and logistics structures are likely to evolve even further in the coming years.

Delivery Partners Easing the Way

Presently, the overall spectrum of urban commercial delivery is changing at a rapid pace. Urbanization has a lot to do with the increase in the demand for last-mile delivery. Several companies, including e-grocers, such as Amazon and Flipkart; food-delivery platforms, including Zomato and Swiggy; and online pharmacy companies, such as PharmEasy and 1mg, are snowballing their online revenue by offering home deliveries through bikes and scooters in short time.

Hence, with the growth in the e-commerce sector, there has been an increase in the need for last-mile delivery solutions.

Exploring the Growth and Opportunities in the Last Mile Delivery Market

What is Age-Related Macular Degeneration?

Age-related macular degeneration (AMD) is an eye illness that can have an adverse impact or blur your vision. It usually occurs after a person attains a certain age — the portion of the eye that controls straight-ahead vision. The macula is a portion of the retina which is the light-sensitive tissue at the back of the eye.

Age-related macular degeneration is a common disorder — it is one of the leading reasons for vision loss for older people. AMD causes partial blindness, not complete blindness, but losing the central vision will be going to make it hard to recognize any face or thing at the first glance, read, drive or do work such as household work, and cooking.

Types and Stages of Age-Related Macular Degeneration

Dry AMD – Most people suffering from AMD have dry AMD. This happens when the macula starts to deplete with age. Dry AMD happens in three stages: early, intermediate, and late. It usually progresses slowly over the period of several years. There’s no treatment for late dry AMD, but you can find ways to save your remaining vision. And if you are suffering from late dry AMD in only 1 eye, then you can take steps to guard your other eye.

Wet AMD – It is known as advanced neovascular AMD, this is not that common, and it grows at a faster pace in comparison to dry AMD. Dry AMD can turn into wet AMD. It occurs when abnormal blood vessels accumulate at the back the eye and harms the macula. But the only good thing about wet AMD is that the cure is available.

Only a limited number of medications are licensed to cure this illness, habitually by anti-VEGFs. Such medicines require regular and uncomfortable intraocular injections, which improves the strain and source non-adherence to treatment.

How Can you Lower the Risk for AMD?

You can lower the risk of AMD (or slow vision loss from AMD) by making these healthy choices:

Don’t smoke
Do regular physical exercise
Keep blood pressure and cholesterol levels in check
Eat healthy foods, like leafy green vegetables and fish

Spectroscopy Technique Led Process Analytical Technology Market

The term “process analytical technology” (PAT) refers to a system for the analysis and control of production processes that measures essential quality criteria and performance characteristics of raw and in-process materials. It makes it possible to use in-process data to evaluate a batch’s quality during manufacturing, greatly lowering the requirement for final product testing, and thus shortening lead times.

Moreover, PAT has been crucial to the pharmaceutical industry’s process development and scale-up of asymmetric chiral compound syntheses, including active pharmaceutical ingredients. Thus, the process analytical technology market is expected to hit USD 13,626.5 million by 2030, as per P&S Intelligence.

Rising Importance of PAT in Pharmaceutical Industry

The pharmaceutical manufacturers category holds the largest share, of 67%, in the market. This is due to the growing importance of PAT in the pharmaceutical industry’s process development and scaling-up of asymmetric syntheses of chiral compounds, including active medicinal components.

Moreover, the category of biopharmaceutical manufacturers is predicted to register the fastest growth rate. This is a result of the growing biotechnology sector and increasing requirement for biochemical analysis brought on by the acceptance and introduction of several biologic medications.

A Sample Can Be Examined at Various Stages Using Spectroscopy

In 2022, the spectroscopy technique accounted for the largest share, 52.2%, in the market, and this category is predicted to maintain the fastest rate in the years to come. This is explained by the rise in pharmaceutical and biopharmaceutical R&D efforts and the accompanying process optimization in technology.

Rising Government Investment in Biotechnology and Pharmaceutical Sectors in APAC

Moreover, the European region is set to advance at an 18.2% rate in the future years. Despite maturing, the region’s need for PAT products is mostly driven by the existence of large analytical technology businesses, a growing emphasis on quality, the expansion of the biotechnology sector, and rising R&D spending by pharmaceutical firms.

Ventilator Market to Grow due to Rising Preference for Home Healthcare Solutions

The ventilator industry garners $1,560.30 million revenue, and is projected to contribute $2,887.32 million revenue in 2030, rising at a rate of 7.1%. It is led by the growing prevalence of chronic diseases such as asthma, and chronic obstructive pulmonary disease across the world.

In addition, the industry is projected to rise in the coming years, due to increasing incidences of preterm births, a surging elderly population, a rising number of ICU beds, and a growing number of COVID-19 patients.

Ventilators are also known as breathing machines. They help the lungs to work effectively. It serves as a lifesaving machine if you have developed a disease that makes breathing difficult on your own.

It helps in pushing the air in and out of the lungs to cater to the oxygen need of the body. A fitted mask can help in getting enough oxygen from the ventilator to the lungs. In a more serious condition, a breathing tube is inserted down the throat for supplying oxygen to the lungs.

A doctor or respiratory therapist controls the amount of oxygen that needs to be pushed into the lungs by the ventilator.

Ventilators serve as breathing aids and are widely used in healthcare facilities, including nursing homes, hospitals, private residences, and long-term care institutions. Severe COVID-19 patients at high risk of respiratory failure can be benefitted effectively through ventilators.

The major advantages of ventilators include weaning, improved oxygenation, and lesser damage to the lungs are projected to boost the industry revenue.

In addition, ventilators have transformed effectively with technological developments, such as advancements in ventilator sensor technologies, and the development of portable ventilators.

Moreover, the rising demand for home healthcare services provides better opportunities to industry players. The home healthcare ventilator demand is rising, due to the convenience offered them and low cost.

Rising Disease Prevalence To Drive Professional Acne Treatment Market to $13,124.5 Million by 2030

From $6,298.9 million in 2020, the global professional acne treatment market value is predicted to reach $13,124.5 million by 2030, at a 7.6% CAGR between 2020 and 2030.

The market is being driven by the following factors:

Rising Prevalence of Acne: Almost 90% of the people on earth, especially young adults and adolescents, get acne at some point in their lives. Moreover, the Global Burden of Disease study estimates the 2019 incidence of this common dermatological issue at 50 million cases in the U.S. alone.
Adoption of Sedentary Lifestyle: This is another key driver for the professional acne treatment market as being less physically active leads to a rise in weight and the levels of lipids in the body. This, in turn, upsets the hormone concentration, which results in an array of skin diseases, including hormonal acne.

The coming years will be characterized by the faster growth of the inflammatory bifurcation in the professional acne treatment market, on the basis of acne type. This kind of acne is considered severer than the non-inflammatory type, and it is often painful. Additionally, inflammatory acne cannot be cured by most of the drugs available over the counter (OTC), which is why a professional’s intervention is preferred.

Nowadays, the increasing focus of pharmaceutical companies on introducing new products is becoming a prominent trend in the professional acne treatment market. For example, in August 2020, Cassiopea SpA received the U.S. Food and Drug Administration (FDA) approval for Winlevi, an acne treatment cream derived from clascoterone. This cream has been developed for treating acne in patients aged 12 years and above. Similarly, in February 2021, VYNE Therapeutics Inc. received the FDA approval for its AMZEEQ (minocycline) topical foam. This foam is designed to treat inflammatory lesions caused by non-nodular moderate-to-severe acne in children aged nine years or more and adults.

The acne type segment of the professional acne treatment market is bifurcated into inflammatory and non-inflammatory. Of these, the inflammatory category generated the higher revenue in 2020 due to the surging need for an effective treatment for inflammatory acne, as it is usually painful. A large number of pharmaceutical companies are offering branded and generic drugs for inflammatory acne, as the commonly available benzoyl-peroxide and salicylic-acid-based over-the-counter (OTC) products are not completely effective on it.

High Burden of Chronic Diseases To Drive Active Pharmaceutical Ingredient Demand

The International Agency for Research on Cancer (IARC) states that 10 million cancer deaths and 19.3 million new cancer cases were recorded in 2020. As per the IARC, 1 in 5 people around the world develops cancer during their lifetime. Further, the World Health Organization (WHO) estimates that approximately 17.9 million human lives were lost due to cardiovascular diseases (CVDs) in 2019. Additionally, the WHO states that over 3 million people each year die of chronic obstructive pulmonary disease (COPD), accounting for over 6% of the global deaths.

The rising incidence of such chronic diseases is projected to propel the active pharmaceutical ingredient (API) market at a CAGR of 6.9% during the forecast period (2021–2030). Additionally, P&S Intelligence states that the booming geriatric population will help the market revenue surge from $184,311.2 million in 2020 to $357,005.7 million by 2030. According to the United Nations Department of Economic and Social Affairs (UNDESA), the number of people aged 65 years or above will increase from 727 million in 2020 to around 1.5 billion by 2050.

Nowadays, captive and merchant manufacturers are producing generic and innovative APIs, which are available through online and offline channels. In contemporary times, innovative APIs are being used in higher quantities due to the mounting focus of pharmaceutical companies on developing new and more-effective medicines. In the coming years, captive manufacturers will emerge as the larger producer of APIs due to the stringent quality control and drug safety guidelines the pharma sector is subject to and the higher budgets captive companies possess for research and development (R&D).

The therapeutic application segment of the active pharmaceutical ingredient market is categorized into CVDs, communicable diseases, diabetes, oncology, pain management, respiratory diseases, and others. Among these, the oncology category held the largest market share in 2020, primarily on account of the high burden of cancer and extensive demand for highly potent APIs (HPAPIs) for cancer treatment. The WHO estimates that cancer caused approximately 10 million fatalities around the world in 2020. It also states that 1.93 million, 2.21 million, and 2.26 million people were diagnosed with colon and rectum, lung, and breast cancer, respectively, in 2020.

In recent years, pharma firms, such as Eli Lilly and Company, Mallinckrodt plc, Merck & Co. Inc., Lupin Limited, Johnson & Johnson, STADA Arzneimittel AG, AbbVie Inc., MSN Laboratories Pvt. Ltd., Novartis AG, Sun Pharmaceutical Industries Ltd., Pfizer Inc., AstraZeneca plc, and Sanofi, have been introducing new products, entering into collaborations and partnerships, and expanding their production capacities, to offer APIs to a greater number of customers. For example, in July 2021, Pfizer Inc. collaborated with Arvinas Inc. to develop and sell PROTAC estrogen receptor protein degrader ARV-471.

Globally, the North American active pharmaceutical ingredient market is expected to generate the highest revenue during the forecast period, owing to the rising burden of chronic diseases, mounting demand for specialty drugs and biologics, surging government focus on generic drugs, increasing technological advancements, and soaring number of R&D initiatives in the pharmaceutical industry. Moreover, the growing public awareness regarding numerous lifestyle-related diseases, such as diabetes, is expected to drive the API demand in the region.

How Wearable Electrodes Can Help in EKG Monitoring?

The use of wearables for health and wellness monitoring is quickly growing. In the years gone by, wearable technology has become popular. For several years, wearables have offered elementary features like step count. Though, over time these features have grown to offer more cutting-edge physical measurements like heart electrical activity.

ECG monitoring is becoming one of the most striking health features of smartwatches. With CVD being one of the foremost reasons of worldwide deaths, the usage of smartwatches to monitor patients remotely could improve the care of heart injury.’

Dry Electrode challenges in EKG development

For detecting EKG, electrodes are needed on a device. This detection interface is a critical constituent in allowing the correctness that will be compulsory, but it can be difficult to implement, particularly with the use of dry electrodes.

When working at electrode stage of the cycle of EKG development, there are numerous challenges like physical design, electrode material choice, the characteristics of the skin location, aesthetic requirements as well as meeting the complete performance necessities of end device. On system level, some of these challenges can be lessened through intelligent signal conditioning algorithms, though, taking a holistic method and tackling all parts of the signal chain will guarantee a world class customer experience.

Some issues faced with electrodes are:

Electrode Skin Interface

Skin is the largest body organ, and is fabricated from numerous components. The epidermis, has a comparatively high impedance opposing the transfer of the EKG signal. In a wet electrode, this is lessened by the conductive electrolyte; in dry electrodes, sweat executes this function. The electrode alters this charge in sweat into electric charge that can be used by the device hardware.

Dry Electrode Mechanical Design

The EKG dry electrodes performance can be impacted by position, size, and surface finish. For a given material, dissimilar sizes and the body position can affect the contact with the skin and the subsequent signal can vary suggestively in quality. The finish of the surface can alter the contact mechanisms, and some coverings can even further obstruct the movement of the EKG signal.

A good amount of data can be collected with the help of wearable sensors for monitoring and recording real-time info about patients’ health. So, it is vital for managing and overcoming these issues to let better-quality sensor performance.

With the increase in technology in the medical industry, medical electrodes are high in demand worldwide.

Browse Full Report Medical Electrodes Market Key Drivers

Increasing Incidence of Chronic Diseases Driving Advancement of Chronic Pain Treatment Market

From $77.8 billion in 2019, the global chronic pain treatment market is predicted to reach a value of $151.7 billion by 2030. According to the estimates of P&S Intelligence, a market research company based in India, the market would advance at a CAGR of 6.5% between 2020 and 2030. The market is being driven by the rising government support for various chronic pain treatment procedures, the surging geriatric population, and the growing incidence of chronic health problems around the world.

The governments of many countries across the world are launching initiatives for raising public awareness about advanced pain treatment items and providing funding for the same, thereby fueling the expansion of the industry. For example, the Developing Countries Project of the International Association for the Study of Pain (IASP) was implemented between January and March 2018 for advancing pain treatment practice and education in the emerging economies with the help of grants.

As per the 2019 World Population Ageing report, there were as many as 703 million persons in the age bracket- 65 years or above all over the world in that year. The report said that over half of the geriatric people in the world in 2019 suffered from multiple chronic health ailments. The rising incidence of chronic diseases is another important factor driving the progress of the market. Orthopedic diseases, neurological disorders, and cancer cause long-term pain in patients.

As per the WHO, the low- and middle-income countries witness the deaths of nearly 70% of the total worldwide cancer deaths. Furthermore, migraine, lower back pain, joint pain, and neck pain generate huge requirement for pain treatment services such as psychological therapies, neuroablation, and physiotherapy throughout the world. Many drugs produced by the players operating in the industry for the treatment of various chronic diseases are currently under clinical trials.

Depending on product, the chronic pain treatment market is classified into devices and drugs. Between these, the drugs category recorded higher growth in the market in the past years. Globally, the market registered the highest growth in North America during the last few years and this trend will continue in the upcoming years as well. This would be because of the soaring population of geriatric people in the regional countries.

Hence, it can be safely concluded that the market will demonstrate huge growth all over the world in the forthcoming years, primarily because of the rising incidence of chronic diseases and the surging geriatric population in several countries around the world.